# European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR

> **NCT02035540** · — · COMPLETED · sponsor: **corlife** · enrollment: 121 (actual)

## Conditions studied

- Heart Valve Disease

## Interventions

- **OTHER:** Decellularized human valves

## Key facts

- **NCT ID:** NCT02035540
- **Lead sponsor:** corlife
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035540, "European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02035540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*